| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |